Skip to content
OmniAb
  • About
    • Team
    • Board of Directors
    • Careers
  • Technology
    • Overview
    • Antibody Generation
      • Antigen Design
      • OmniRat
      • OmniMouse
      • OmniChicken
      • OmnidAb
      • OmniUltra
      • OmniTaur
      • Bispecific Platforms
    • xPloration Screening
    • Antibody Optimization
      • Fc-Silencing Technology
    • Ion Channel and Transporter Technology
    • In Silico Technologies
    • Scientific Publications
  • Partnerships
    • Overview
    • Why Partner with OmniAb?
    • Partner Pipeline
    • Contact Business Development
  • Investors
    • Overview
    • News
    • Events & Presentations
    • Stock Info
    • SEC Filings
    • Financials
    • Governance
      • Governance Documents
      • Executive Officers
      • Board of Directors
      • Board Committees
    • Environment
    • Resources
      • Investor FAQs
      • Information Request Form
      • Investor Email Alerts
      • Investor Contacts
  • Contact
OmniAb
  • About
    • Team
    • Board of Directors
    • Careers
  • Technology
    • Overview
    • Antibody Generation
      • Antigen Design
      • OmniRat
      • OmniMouse
      • OmniChicken
      • OmnidAb
      • OmniUltra
      • OmniTaur
      • Bispecific Platforms
    • xPloration Screening
    • Antibody Optimization
      • Fc-Silencing Technology
    • Ion Channel and Transporter Technology
    • In Silico Technologies
    • Scientific Publications
  • Partnerships
    • Overview
    • Why Partner with OmniAb?
    • Partner Pipeline
    • Contact Business Development
  • Investors
    • Overview
    • News
    • Events & Presentations
    • Stock Info
    • SEC Filings
    • Financials
    • Governance
      • Governance Documents
      • Executive Officers
      • Board of Directors
      • Board Committees
    • Environment
    • Resources
      • Investor FAQs
      • Information Request Form
      • Investor Email Alerts
      • Investor Contacts
  • Contact

Scientific Publications

Presentations
OmniUltra™: Leveraging Evolutionary Distance for the Discovery of Ultralong CDRH3 Antibodies with Broad Epitope Coverage

Antibody & Engineering Therapeutics US, 2025
...
Read More

Presentations
OmniUltra™: A New In Vivo Platform for Discovery of Novel Mini-Proteins and Structured Peptides

Antibody & Engineering Therapeutics US, 2025
...
Read More

Presentations
Development of OmniUltra™: A Transgenic Chicken System for the Generation of Ultralong CDRH3 Antibodies, Mini-Proteins,...

Antibody Engineering & Therapeutics US, 2025
...
Read More

Presentations
Empowering the Efficient Discovery of Ultralong CDRH3 Antibodies with High-Throughput xPloration® Workflows

Antibody & Engineering Therapeutics US, 2025
...
Read More

Presentations
xPloration®: Simplifying Deep Antibody Mining for Maximum Impact

PEGS Summit Boston, 2025
...
Read More

Publications
Heavy chain-only antibodies with a stabilized human VH in transgenic chickens for therapeutic antibody discovery

mAbs, 2024
...
Read More

Publications
Chickens with a Truncated Light Chain Transgene Express Single-Domain H Chain-Only Antibodies

Journal of Immunology, 2024
...
Read More

Presentations
Deep Screening in Harmony with AI for Bispecific Antibody Discovery

PEGS Summit Boston, 2024
...
Read More

Presentations
Wrangling Diverse OmniAb Antibody Repertoires with OmniDeep

Antibody Engineering & Therapeutics US, 2023
...
Read More

Presentations
OmnidAb: Heavy Chain-Only Transgenic Chickens Produce Human Antibodies with Robust Immune Repertoires and High-Affinity Binding

Antibody Engineering & Therapeutics US, 2023
...
Read More

Presentations
Heavy Chain-Only Transgenic Chickens Produce Human Antibodies with Robust Immune Repertoires and High-Affinity Binding

PEGS Summit Europe, 2023
...
Read More

Presentations
Wrangling Diverse OmniAb Antibody Repertoires with OmniDeep™

PEGS Summit Boston, 2023
...
Read More
  • 1
  • 2
  • 3
  • 4
Loading...

About

  • Team
  • Board of Directors
  • Careers

Partnerships

  • Overview
  • Why Partner with OmniAb?
  • Partner Pipeline
  • Contact Business Development

Technology

  • Overview
  • Antigen Design
  • Antibody Generation
  • Antibody Optimization
  • Ion Channel and Transporter Technology
  • Scientific Publications

OmniAb, Inc.
5980 Horton Street
Suite 600
Emeryville, CA 94608

Contact | Privacy Policy | Disclaimer

© 2025 OmniAb, Inc. All rights reserved.